Clinical trial · Observational
Evaluation of Sleep Quality in Head and Neck Cancer Patients Throughout Treatment Course
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): PI agreed to close study as prompted by PRMC inquiry
Summary
Brief summary (as posted)
This study examines how head and neck cancer treatment affects quality of sleep over time and factors that contribute to sleep quality. Sleep plays a critical role in healing and quality of life, and recent studies investigating sleep disorders in head and neck cancer patients reveal sleep quality is a major determinant of post-treatment outcomes. Information from this study may help researchers better understand how treatment impacts sleep quality so that they can make changes that may help improve patient sleep quality.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Malignant Head and Neck Neoplasm | Malignant Head and Neck Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Survey Administration | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Observational (survey)
- description
- COHORT 1-TP1: Patients complete surveys over 20 minutes on post-op day 3 and on day of discharge (or within 1 week). COHORT 1-TP2: Patients complete surveys over 15 minutes at all regularly scheduled follow-up appointments (approximately 1 month, 3 months, 6 months, 12 months). COHORT 2: Patients complete surveys over 15 minutes once.
- interventionNames
- Other: Survey Administration
Primary outcomes (10)
- measure
- Time in bed
- timeFrame
- Up to study completion; approximately 12 months
- description
- The time difference between time to get into bed and time to get up, measured in minutes
- measure
- Sleep latency
- timeFrame
- Up to study completion; approximately 12 months
- description
- How long it takes to sleep, measured in minutes.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Males and females * Adult at least 18 years old * Capable of giving informed consent * Diagnosed with head and neck cancer (previously untreated, any stage) * Treatment plan involves surgery * Willing to comply with all study procedures and be available for the duration of the study * English-speaking Exclusion Criteria: * Non-English speaking * Pre-existing sleep disorder defined below: * Obstructive sleep apnea * Insomnia * Narcolepsy * Restless leg syndrome * Rapid eye movement (REM) sleep behavior disorder
References
Publications (0)
Data not yet available